Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry

BACKGROUND: Cannabidiol (CBD) is a major chemical compound present in Cannabis sativa. CBD is a nonpsychotomimetic substance, and it is considered one of the most promising candidates for the treatment of psychiatric disorders. OBJECTIVE: The aim of this review is to illustrate the state of art abou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evid Based Complement Alternat Med
Main Authors: Calapai, Gioacchino, Mannucci, Carmen, Chinou, Ioanna, Cardia, Luigi, Calapai, Fabrizio, Sorbara, Emanuela Elisa, Firenzuoli, Bernardo, Ricca, Valdo, Gensini, Gian Franco, Firenzuoli, Fabio
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6735178/
https://ncbi.nlm.nih.gov/pubmed/31558911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/2509129
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados